1. mAbDx Chief Scientific Officer Michael Marusich, Ph.D., presents recent research to identify and characterize new mtDAMPs that drive the Systemic Inflammatory Response Syndrome (SIRS) after trauma

    Wed 11 September 2013

    mAbDx Chief Scientific Officer Michael Marusich, Ph.D., presented a research report titled “Defining the contribution of mitochondrial peptides to SIRS after tissue injury” at the 2013 Mérieux Research Grants Meeting, held in Annecy, France, Sept 11-13.  The work is a collaborative research project by Michael Marusich, Ph.D., mAbDx …

    read more
  2. mAbDx moves into a new custom-built biotechnology laboratory in the recently completed Lewis Integrative Sciences Building on the University of Oregon campus

    Sun 01 September 2013

    mAbDx has relocated into private laboratory and office space in the newly completed Lewis Integrative Sciences Building on the campus of the University of Oregon.  The laboratory is designed for biotechnology research, in particular the development, characterization and validation of novel monoclonal antibodies and immunoassays.

    read more
  3. Michael Marusich, Ph.D., mAbDx, and Carl Hauser, M.D., Harvard, awarded collaborative Mérieux Research Grant to identify and characterize new mtDAMPs that drive systemic inflammation after trauma

    Mon 01 July 2013

    mAbDx is pleased to announce that Michael Marusich, Ph.D., mAbDx, and Carl Hauser, M.D., Harvard, have been awarded a collaborative Mérieux Research Grant to identify new mitochondrial Damage Associated Molecular Patterns (mtDAMPs) that drive Systemic Inflammatory Response Syndrome (SIRS) after trauma.  Post-trauma SIRS is a common, potentially life-threatening …

    read more

« Page 3 / 5 »